ANGLE plc (LON:AGL – Get Free Report)’s stock price passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of GBX 2.35 and traded as high as GBX 2.90. ANGLE shares last traded at GBX 2.35, with a volume of 1,682,496 shares trading hands.
ANGLE Price Performance
The company has a quick ratio of 6.18, a current ratio of 3.13 and a debt-to-equity ratio of 31.35. The business’s 50 day moving average is GBX 2.35 and its 200-day moving average is GBX 2.35. The firm has a market capitalization of £7.58 million, a P/E ratio of -0.49 and a beta of 0.22.
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
Read More
- Five stocks we like better than ANGLE
- AI Server Earnings: Wall Street Sees One Clear Standout
- Navitas: NVIDIA’s AI Power Broker?
- A Lulu of a Miss Sends Lululemon to New Lows—Look Out Below
- NVIDIA’s New Power Play: Why Fluence Is Surging
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.
